Apr 14, 2022 - Health

MS has an economic cost of $85.4 billion, study says

Tina Reed

A health cross with money at its base. — Illustration: Aïda Amer/Axios

The economic cost of multiple sclerosis, or MS, was about $85.4 billion in the U.S. in 2019, according to research published Wednesday in the online issue of Neurology.

Driving the news: According to the report, MS has a direct medical cost of $63.3 billion and indirect and non-medical costs of $22.1 billion.

Retail prescription medication (54%), clinic administered drugs (12%), medication and administration and outpatient care (9%) were the three largest components of the direct costs.
Lost earnings due to premature death, lost productivity and absenteeism were the largest components of indirect costs.
Researchers also found the average annual excess medical costs per person with MS were about $65,600.

Add Axios on Google

MS has an economic cost of $85.4 billion, study says

What to read next